INTERNATIONAL PATENT: CUE BIOPHARMA, INC. FILES APPLICATION FOR "FIXED DOSAGES OF T CELL MODULATORY POLYPEPTIDES COMPRISING PEPTIDE-MHC COMPLEXES"

GENEVA, March 19 -- CUE BIOPHARMA, INC. (40 GUEST STREETBoston, Massachusetts 02135) filed a patent application (PCT/US2025/045233) for "FIXED DOSAGES OF T CELL MODULATORY POLYPEPTIDES COMPRISING PEPTIDE-MHC COMPLEXES" on Sep 05, 2025. With publication no. WO/2026/055550, the details related to the patent application was published on Mar 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): QUAYLE, Steven Norman (c/o Cue Biopharma, Inc.40 Guest StreetBoston, Massachusetts 02135), LEVISETTI, Matteo Giacomo (c/o Cue Biopharma, Inc.40 Guest StreetBoston, Massachusetts 02135)

Abstract: This discl...